The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction. 1988

R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
Department of Cardiology, University Hospital Leiden, The Netherlands.

The acute effects on left ventricular function of nisoldipine were studied in six patients 56 +/- 12 hours (range 44 to 72 hours) after the onset of uncomplicated acute myocardial infarction. Nisoldipine was administered as a 4.5 micrograms/kg intravenous bolus over 3 minutes followed by an infusion of 0.2 microgram/kg during 60 minutes. Radionuclide angiography and two-dimensional echocardiography were performed before and during infusion with nisoldipine. The left ventricular ejection fraction increased significantly from 38% +/- 10% to 49% +/- 10% (P = 0.028) during nisoldipine infusion. Regional wall motion index was determined both by radionuclide and by two-dimensional echocardiography and showed a significant change during nisoldipine infusion from 1.9 +/- 0.3 to 1.5 +/- 0.3 (p = 0.028, radionuclide angiography) and from 0.7 +/- 0.2 to 0.3 +/- 0.2 (p = 0.043, two dimensional echocardiography). Heart rate increased significantly from 78 +/- 12 min-1 to 92 +/- 13 min-1 (p = 0.028), but mean double product did not change significantly during nisoldipine infusion. It is concluded that nisoldipine significantly improves global and regional left ventricular function in patients shortly after acute myocardial infarction. This beneficial effect may, however, be partially offset by an increase in heart rate. Since mean double product did not change, it is suggested that nisoldipine may improve coronary blood flow in patients with acute myocardial infarction.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
December 1992, European heart journal,
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
May 1994, Cardiovascular drugs and therapy,
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
October 1987, European heart journal,
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
January 1982, Cardiology,
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
July 1985, The American journal of cardiology,
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
April 1979, Deutsche medizinische Wochenschrift (1946),
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
May 2001, Japanese circulation journal,
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
January 1976, European journal of intensive care medicine,
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
June 1997, Cardiologia (Rome, Italy),
R C de Nooijer, and E E van der Wall, and V M Cats, and G van Herpen, and A van der Laarse, and J A Blokland, and W Jaarsma, and J W Arndt, and A V Bruschke
January 1990, Annales de medecine interne,
Copied contents to your clipboard!